Entasis Therapeutics Holdings Inc.(ETTX)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ETTX Entasis Therapeutics Holdings Inc.

停牌 11-04 17:29:54 EST

2.19

+0.00

0.00%

最高2.19	最低2.19	成交量0.00
今开2.19	昨收2.19	日振幅0.00%
总市值1.05亿	流通市值3,503万	总股本4,785万
成交额15.11万	换手率0.00%	流通股本1,599万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ETTX","market":"US","secType":"STK","nameCN":"Entasis Therapeutics Holdings Inc.","latestPrice":2.19,"timestamp":1657310400000,"preClose":2.19,"halted":3,"volume":0,"delay":0,"floatShares":15994442,"shares":47851779,"eps":-1.123122,"marketStatus":"停牌","marketStatusCode":4,"change":0,"latestTime":"11-04 17:29:54 EST","open":2.19,"high":2.19,"low":2.19,"amount":151146.158388,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.123122,"exchange":"NASDAQ","tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1730768400000},"adr":0,"listingDate":1537934400000,"adjPreClose":2.19,"adrRate":0,"volumeRatio":0},"requestUrl":"/m/hq/s/ETTX","defaultTab":"news","newsList":[{"id":"2186368092","title":"Entasis Therapeutics Holdings, Inc.盘中异动 急速拉升5.70%","url":"https://stock-news.laohu8.com/highlight/detail?id=2186368092","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2186368092?lang=zh_cn&edition=full","pubTime":"2021-11-25 02:06","pubTimestamp":1637777207,"startTime":"0","endTime":"0","summary":"北京时间2021年11月25日02时06分，Entasis Therapeutics Holdings, Inc.股票出现波动，股价急速拉升5.70%。Entasis Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为0.25%。其相关个股中，Soligenix Inc Warrant 2016-14.11.21 On Soligenix、Logicvision Inc Com New、Palatin Technologies Inc涨幅较大，Ocuphire Pharma Inc、Aptevo Therapeutics Inc、Logicvision Inc Com New较为活跃，换手率分别为449.71%、335.35%、275.03%，振幅较大的相关个股有Logicvision Inc Com New、Better Therapeutics Inc、Palatin Technologies Inc，振幅分别为101.92%、57.25%、52.00%。Entasis Therapeutics Holdings, Inc.公司简介：Entasis Therapeutics Holdings Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":"https://static.tigerbbs.com/f25970ebf4293eec7586423288711d3f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/f25970ebf4293eec7586423288711d3f"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111250206477902be44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111250206477902be44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4167","TERN","BK4539","ETTX","BK4191","OLPX","ALVU","BK4183","FWRG","HCTI","BK4007","CRCT","BK4209"],"gpt_icon":0},{"id":"2180799686","title":"Entasis Therapeutics Holdings, Inc.盘中异动 股价大跌5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2180799686","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2180799686?lang=zh_cn&edition=full","pubTime":"2021-11-04 21:31","pubTimestamp":1636032671,"startTime":"0","endTime":"0","summary":"北京时间2021年11月04日21时31分，Entasis Therapeutics Holdings, Inc.股票出现异动，股价快速跳水5.25%。Entasis Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体跌幅为3.49%。其相关个股中，Evaxion Biotech As、Artelo Biosciences Inc、Better Therapeutics Inc涨幅较大，Artelo Biosciences Inc、Evaxion Biotech As、Better Therapeutics Inc较为活跃，换手率分别为75.55%、30.57%、20.19%，振幅较大的相关个股有Evaxion Biotech As、Immunic Inc、Aravive Inc，振幅分别为48.15%、9.51%、8.23%。Entasis Therapeutics Holdings, Inc.公司简介：Entasis Therapeutics Holdings Inc是一家临床阶段的生物制药公司。消息层面，截至21时31分，Entasis Therapeutics Holdings, Inc.股票正面舆情新闻比例100%。","market":"us","thumbnail":"https://static.tigerbbs.com/b8906c2117cf409a3cc5087f96741bce","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/b8906c2117cf409a3cc5087f96741bce"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111042131117a063560&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202111042131117a063560&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCTI","ALVU","CRCT","ETTX","TERN","OLPX","FWRG"],"gpt_icon":0},{"id":"2178247856","title":"Entasis Therapeutics Holdings, Inc.盘中异动 大幅拉升5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2178247856","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2178247856?lang=zh_cn&edition=full","pubTime":"2021-10-26 01:42","pubTimestamp":1635183753,"startTime":"0","endTime":"0","summary":"北京时间2021年10月26日01时42分，Entasis Therapeutics Holdings, Inc.股票出现波动，股价大幅上涨5.30%。Entasis Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.80%。其相关个股中，Outlook Therapeutics Inc C/Wts 18/02/2022 Ser A、Nutriband, Inc.、Avenue Therapeutics Inc涨幅较大，Progenity Inc、Kiromic Biopharma Inc、Context Therapeutics, Inc.较为活跃，换手率分别为79.89%、71.82%、62.43%，振幅较大的相关个股有Kiromic Biopharma Inc、Jasper Therapeutics Inc、Nutriband Inc Warrant 2021- On Nutriband，振幅分别为48.96%、22.93%、21.59%。Entasis Therapeutics Holdings, Inc.公司简介：Entasis Therapeutics Holdings Inc是一家临床阶段的生物制药公司。公司主要产品包括，zoliflodacin，etx0282cpdp和nbp program。","market":"us","thumbnail":"https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/e0ab8365ea89ee143187cbf51d23ba8f"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202110260142337ddf33a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202110260142337ddf33a7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FWRG","HCTI","OLPX","ETTX","TERN","CRCT","ALVU"],"gpt_icon":0},{"id":"2176105398","title":"Entasis Therapeutics Holdings, Inc.盘中异动 快速上涨6.11%报3.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2176105398","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2176105398?lang=zh_cn&edition=full","pubTime":"2021-10-19 21:31","pubTimestamp":1634650276,"startTime":"0","endTime":"0","summary":"北京时间2021年10月19日21时31分，Entasis Therapeutics Holdings, Inc.股票出现波动，股价急速上涨6.11%。截至发稿，该股报3.30美元/股，成交量229.742万股，换手率4.86%，振幅3.62%。Entasis Therapeutics Holdings, Inc.股票所在的生物技术行业中，整体涨幅为1.11%。其相关个股中，Inflarx N V、Progenity Inc、Edesa Biotech Inc涨幅较大，Edesa Biotech Inc、Galera Therapeutics, Inc.、Inflarx N V较为活跃，换手率分别为26.61%、17.75%、15.96%，振幅较大的相关个股有180 Life Sciences Corp C/Wts 07/11/2025、Surrozen, Inc.、Progenity Inc，振幅分别为8.18%、7.04%、6.02%。Entasis Therapeutics Holdings, Inc.公司简介：Entasis Therapeutics Holdings Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":"https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021101921311779fe2e8f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021101921311779fe2e8f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["FWRG","HCTI","CRCT","ETTX","TERN","OLPX","ALVU"],"gpt_icon":0},{"id":"2119946363","title":"Entasis Therapeutics Hldgs Inc盘中异动 快速上涨5.63%报2.99美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2119946363","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2119946363?lang=zh_cn&edition=full","pubTime":"2021-03-15 22:53","pubTimestamp":1615819985,"startTime":"0","endTime":"0","summary":"北京时间2021年03月15日22时53分，Entasis Therapeutics Hldgs Inc股票出现异动，股价急速拉升5.63%。截至发稿，该股报2.99美元/股，成交量17.5294万股，换手率0.49%，振幅7.41%。Entasis Therapeutics Hldgs Inc股票所在的生物技术行业中，整体涨幅为0.91%。其相关个股中，Rubius Therapeutics Inc、Intec Pharma Ltd、依特钠涨幅较大，Intec Pharma Ltd、Acer Therapeutics Inc、Timber Pharmaceuticals Inc较为活跃，换手率分别为223.26%、116.88%、43.03%，振幅较大的相关个股有Rubius Therapeutics Inc、Intec Pharma Ltd、Acer Therapeutics Inc，振幅分别为126.60%、38.98%、38.42%。Entasis Therapeutics Hldgs Inc公司简介：Entasis Therapeutics Holdings Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":"https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/753c9aba3202037bc97463c545d5d015"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103152253067875a96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103152253067875a96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CGEM","SANA","APR","LABP","ETTX","LHDX"],"gpt_icon":0},{"id":"2119964967","title":"Entasis Therapeutics Hldgs Inc盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2119964967","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2119964967?lang=zh_cn&edition=full","pubTime":"2021-03-13 00:35","pubTimestamp":1615566951,"startTime":"0","endTime":"0","summary":"北京时间2021年03月13日00时35分，Entasis Therapeutics Hldgs Inc股票出现波动，股价急速拉升5.36%。截至发稿，该股报2.75美元/股，成交量6.8575万股，换手率0.19%，振幅2.68%。Entasis Therapeutics Hldgs Inc股票所在的生物技术行业中，整体跌幅为1.11%。其相关个股中，Nls Pharmaceutics Ltd、Entera Bio Ltd、Seelos Therapeutics Inc涨幅较大，Nls Pharmaceutics Ltd、Entera Bio Ltd、Timber Pharmaceuticals Inc较为活跃，换手率分别为1031.91%、415.83%、180.22%，振幅较大的相关个股有Entera Bio Ltd、Nls Pharmaceutics Ltd、Regulus Therapeutics Inc，振幅分别为113.12%、79.08%、44.31%。Entasis Therapeutics Hldgs Inc公司简介：Entasis Therapeutics Holdings Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":"https://static.tigerbbs.com/239de6d52f53f295cfca7ca2933e727c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/239de6d52f53f295cfca7ca2933e727c"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103130035517dcd2c7e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202103130035517dcd2c7e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SANA","LHDX","ETTX","APR","LABP","CGEM"],"gpt_icon":0},{"id":"2113738564","title":"Entasis Therapeutics Hldgs Inc盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2113738564","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2113738564?lang=zh_cn&edition=full","pubTime":"2021-02-23 03:45","pubTimestamp":1614023133,"startTime":"0","endTime":"0","summary":"北京时间2021年02月23日03时45分，Entasis Therapeutics Hldgs Inc股票出现波动，股价急速下跌5.04%。Entasis Therapeutics Hldgs Inc股票所在的生物技术行业中，整体跌幅为1.95%。其相关个股中，克莱瑞恩、Citius Pharmaceuticals Inc、Chromadex Corporation涨幅较大，克莱瑞恩、Citius Pharmaceuticals Inc、Can Fite Biofarma Ltd较为活跃，换手率分别为411.69%、171.47%、83.72%，振幅较大的相关个股有克莱瑞恩、Bellerophon Therapeutics Inc、Citius Pharmaceuticals Inc，振幅分别为32.63%、26.74%、26.70%。Entasis Therapeutics Hldgs Inc公司简介：Entasis Therapeutics Holdings Inc是一家临床阶段的生物制药公司。","market":"us","thumbnail":"https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/082208e3c37780dd55878056410ffa43"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102230345347e62e4a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202102230345347e62e4a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ETTX","SANA","LHDX","LABP","CGEM","APR"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.entasistx.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0138},{"period":"1month","weight":0.0038},{"period":"3month","weight":0.0716},{"period":"6month","weight":0.1169},{"period":"1year","weight":0.3257},{"period":"ytd","weight":0.2014}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Entasis Therapeutics Holdings Inc.于2018年3月根据特拉华州法律注册成立。该公司是一家临床阶段的生物制药公司，专注于新型抗菌产品的发现，开发和商业化，以治疗由多重耐药革兰氏阴性菌引起的严重感染。利用其目标设计平台，他们设计并开发了针对临床验证机制的候选产品，以解决抗生素耐药性问题。Entasis Therapeutics Holdings Inc.的主要产品是药物ETX2514以及其他候选产品之一ETX0282抑制了最常见的细菌耐药形式之一 内酰胺酶，因为它们具有灭活b-的能力而得名。内酰胺类抗生素，是最常用的一类抗生素。通过阻断这种抗性机制，当与β-内酰胺抗生素联合给药时，这些候选产物被设计用于恢复那些抗生素的功效。该公司的其他候选产品zoliflodacin针对氟喹诺酮类抗生素的有效作用机制，但这是避免现有的氟喹诺酮耐药性的新颖方式。","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.061239},{"month":2,"riseRate":0.75,"avgChangeRate":0.039392},{"month":3,"riseRate":0.5,"avgChangeRate":-0.107339},{"month":4,"riseRate":0.75,"avgChangeRate":0.011528},{"month":5,"riseRate":0.75,"avgChangeRate":0.047344},{"month":6,"riseRate":1,"avgChangeRate":0.063282},{"month":7,"riseRate":0.25,"avgChangeRate":-0.048227},{"month":8,"riseRate":0.666667,"avgChangeRate":0.101758},{"month":9,"riseRate":0.333333,"avgChangeRate":-0.075884},{"month":10,"riseRate":0.25,"avgChangeRate":-0.198374},{"month":11,"riseRate":0.5,"avgChangeRate":-0.033793},{"month":12,"riseRate":0.5,"avgChangeRate":-0.030291}],"exchange":"NASDAQ","name":"Entasis Therapeutics Holdings Inc.","nameEN":"Entasis Therapeutics Holdings Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Entasis Therapeutics Holdings Inc.(ETTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Entasis Therapeutics Holdings Inc.(ETTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Entasis Therapeutics Holdings Inc.,ETTX,Entasis Therapeutics Holdings Inc.股票,Entasis Therapeutics Holdings Inc.股票老虎,Entasis Therapeutics Holdings Inc.股票老虎国际,Entasis Therapeutics Holdings Inc.行情,Entasis Therapeutics Holdings Inc.股票行情,Entasis Therapeutics Holdings Inc.股价,Entasis Therapeutics Holdings Inc.股市,Entasis Therapeutics Holdings Inc.股票价格,Entasis Therapeutics Holdings Inc.股票交易,Entasis Therapeutics Holdings Inc.股票购买,Entasis Therapeutics Holdings Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Entasis Therapeutics Holdings Inc.(ETTX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Entasis Therapeutics Holdings Inc.(ETTX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况